101 related articles for article (PubMed ID: 15863230)
21. GABAA receptors in nucleus accumbens shell mediate the hyperphagia and weight gain following haloperidol treatment in rats.
Meena H; Nakhate KT; Kokare DM; Subhedar NK
Life Sci; 2009 Jan; 84(5-6):156-63. PubMed ID: 19100273
[TBL] [Abstract][Full Text] [Related]
22. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation.
Snigdha S; Neill JC
Behav Brain Res; 2008 Mar; 187(2):489-94. PubMed ID: 18037171
[TBL] [Abstract][Full Text] [Related]
24. Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study.
Park S; Yi KK; Kim MS; Hong JP
Behav Brain Funct; 2013 Jul; 9():27. PubMed ID: 23866300
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Ratner Y; Gibel A; Yorkov V; Ritsner MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
[TBL] [Abstract][Full Text] [Related]
26. Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats.
Rachoń D; Vortherms T; Seidlová-Wuttke D; Wuttke W
Menopause; 2007; 14(5):925-32. PubMed ID: 17414092
[TBL] [Abstract][Full Text] [Related]
27. Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone.
Montes JM; Rodriguez JL; Balbo E; Sopelana P; Martin E; Soto JA; Delgado JF; Diez T; Villardaga I
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):383-8. PubMed ID: 17129654
[TBL] [Abstract][Full Text] [Related]
28. The atypical antipsychotics quetiapine, risperidone and ziprasidone do not increase insulin release in vitro.
Melkersson K; Jansson E
Neuro Endocrinol Lett; 2005 Jun; 26(3):205-8. PubMed ID: 15990722
[TBL] [Abstract][Full Text] [Related]
29. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats.
Park SW; Lee CH; Lee JG; Lee SJ; Kim NR; Choi SM; Kim YH
J Psychiatr Res; 2009 Jan; 43(3):274-81. PubMed ID: 18656896
[TBL] [Abstract][Full Text] [Related]
31. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
[TBL] [Abstract][Full Text] [Related]
32. Effect of cerebrocrast on body and organ weights, food and water intake, and urine output of normal rats.
Briede J; Stivrina M; Stoldere D; Vigante B; Duburs G
Cell Biochem Funct; 2008 Dec; 26(8):908-15. PubMed ID: 19039818
[TBL] [Abstract][Full Text] [Related]
33. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
[TBL] [Abstract][Full Text] [Related]
34. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Abdul-Monim Z; Reynolds GP; Neill JC
Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
[TBL] [Abstract][Full Text] [Related]
35. Effects of abuse pattern of gestational toluene exposure on metabolism, feeding and body composition.
Jarosz PA; Fata E; Bowen SE; Jen KL; Coscina DV
Physiol Behav; 2008 Mar; 93(4-5):984-93. PubMed ID: 18272189
[TBL] [Abstract][Full Text] [Related]
36. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
37. Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride.
Meisel A; Winter C; Zschenderlein R; Arnold G
Mov Disord; 2004 Aug; 19(8):991-2. PubMed ID: 15300676
[No Abstract] [Full Text] [Related]
38. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats.
Rezvani AH; Caldwell DP; Levin ED
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):190-7. PubMed ID: 16310917
[TBL] [Abstract][Full Text] [Related]
39. A model for antipsychotic-induced obesity in the male rat.
Minet-Ringuet J; Even PC; Lacroix M; Tomé D; de Beaurepaire R
Psychopharmacology (Berl); 2006 Sep; 187(4):447-54. PubMed ID: 16783538
[TBL] [Abstract][Full Text] [Related]
40. Ziprasidone-induced galactorrhea: a case report.
Kopecek M; Bares M; Mohr P
Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
